{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:51:46Z","timestamp":1794210706073,"version":"4.8.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004955","name":"\u00d6sterreichische Forschungsf\u00f6rderungsgesellschaft","doi-asserted-by":"publisher","award":["879117"],"award-info":[{"award-number":["879117"]}],"id":[{"id":"10.13039\/501100004955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"DOI":"10.1186\/s41181-024-00323-6","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:19:14Z","timestamp":1736504354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQ"],"prefix":"10.1186","volume":"10","author":[{"given":"Katar\u00edna","family":"Ben\u010durov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8154-5680","authenticated-orcid":false,"given":"Theresa","family":"Balber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Weissenb\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Friske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Mitterhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Ozenil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"issue":"2","key":"323_CR1","first-page":"198","volume":"14","author":"A Al-Akhras","year":"2024","unstructured":"Al-Akhras A, Hage Chehade C, Narang A, Swami U. PARP inhibitors in metastatic castration-resistant prostate cancer: unraveling the therapeutic landscape. Life (Basel). 2024;14(2):198.","journal-title":"Life (Basel)"},{"issue":"1","key":"323_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41467-017-00393-y","volume":"8","author":"M Asim","year":"2017","unstructured":"Asim M, Tarish F, Zecchini HI, Sanjiv K, Gelali E, Massie CE, et al. Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer. Nat Commun. 2017;8(1):374.","journal-title":"Nat Commun"},{"issue":"1","key":"323_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13550-024-01151-0","volume":"14","author":"K Ben\u010durov\u00e1","year":"2024","unstructured":"Ben\u010durov\u00e1 K, Tran L, Friske J, Bevc K, Helbich TH, Hacker M, et al. An in vivo tumour organoid model based on the chick embryonic chorioallantoic membrane mimics key characteristics of the patient tissue: a proof-of-concept study. EJNMMI Res. 2024;14(1):86.","journal-title":"EJNMMI Res"},{"key":"323_CR4","doi-asserted-by":"crossref","unstructured":"Ben\u010durov\u00e1 K, Friske J, Anderla M, Mayrhofer M, Wanek T, Nics L, et al. CAM-xenograft model provides preclinical evidence for the applicability of [68Ga]Ga-Pentixafor in CRC imaging. Cancers (Basel). 2022;14(22):5549","DOI":"10.3390\/cancers14225549"},{"issue":"6","key":"323_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3382\/ps.0680805","volume":"68","author":"WH Burke","year":"1989","unstructured":"Burke WH, Sharp PJ. Sex differences in body weight of chicken embryos. Poult Sci. 1989;68(6):805\u201310.","journal-title":"Poult Sci"},{"issue":"3","key":"323_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s11307-015-0904-y","volume":"18","author":"B Carney","year":"2016","unstructured":"Carney B, Carlucci G, Salinas B, Di Gialleonardo V, Kossatz S, Vansteene A, et al. Non-invasive PET imaging of PARP1 expression in glioblastoma models. Mol Imaging Biol. 2016;18(3):386\u201392.","journal-title":"Mol Imaging Biol"},{"issue":"7","key":"323_CR7","first-page":"2081","volume":"50","author":"B Chen","year":"2023","unstructured":"Chen B, Ojha DP, Toyonaga T, Tong J, Pracitto R, Thomas MA, et al. Preclinical evaluation of a brain penetrant PARP PET imaging probe in rat glioblastoma and nonhuman primates. EJNMMI. 2023;50(7):2081\u201399.","journal-title":"EJNMMI"},{"issue":"3","key":"323_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s10571-022-01253-0","volume":"43","author":"R \u00c7\u0131nar","year":"2023","unstructured":"\u00c7\u0131nar R, Naz\u0131ro\u011flu M. TRPM2 channel inhibition attenuates amyloid \u03b242-induced apoptosis and oxidative stress in the hippocampus of mice. Cell Mol Neurobiol. 2023;43(3):1335\u201353.","journal-title":"Cell Mol Neurobiol"},{"key":"323_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.dnarep.2018.08.021","volume":"71","author":"AD D'Andrea","year":"2018","unstructured":"D\u2019Andrea AD. Mechanisms of PARP inhibitor sensitivity and resistance. DNA Repair (Amst). 2018;71:172\u20136.","journal-title":"DNA Repair (Amst)"},{"issue":"22","key":"323_CR10","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","volume":"382","author":"J de Bono","year":"2020","unstructured":"de Bono J, Mateo J, Fizazi K, Saad F, Shore N, Sandhu S, et al. Olaparib for metastatic castration-resistant prostate cancer. N Engl J Medicine. 2020;382(22):2091\u2013102.","journal-title":"N Engl J Medicine"},{"issue":"6","key":"323_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s11307-022-01746-w","volume":"24","author":"F Dehdashti","year":"2022","unstructured":"Dehdashti F, Reimers MA, Shoghi KI, Chen DL, Luo J, Rogers B, et al. Pilot study: PARP1 imaging in advanced prostate cancer. Mol Imaging Biol. 2022;24(6):853\u201361.","journal-title":"Mol Imaging Biol"},{"key":"323_CR12","unstructured":"European Directorate for the Quality of Medicines (EDQM), in European Pharmacopoeia 11.2 Monograph 1617 - L\u2013Methionine ([11C]Methyl) Injection, Council Of Europe, Strasbourg, 2023."},{"issue":"1","key":"323_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13550-018-0399-z","volume":"8","author":"PL Donabedian","year":"2018","unstructured":"Donabedian PL, Kossatz S, Engelbach JA, Jannetti SA, Carney B, Young RJ, et al. Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models. EJNMMI Res. 2018;8(1):59.","journal-title":"EJNMMI Res"},{"issue":"1","key":"323_CR14","first-page":"94","volume":"6","author":"CE Edmonds","year":"2016","unstructured":"Edmonds CE, Makvandi M, Lieberman BP, Xu K, Zeng C, Li S, et al. [18F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer. Am J Nucl Med Mol Imaging. 2016;6(1):94\u2013101.","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"7035","key":"323_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt ANJ, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434(7035):917\u201321.","journal-title":"Nature"},{"issue":"6","key":"323_CR16","first-page":"371","volume":"32","author":"P Gebhardt","year":"2013","unstructured":"Gebhardt P, W\u00fcrbach L, Heidrich A, Heinrich L, Walther M, Opfermann T, et al. Dynamic behaviour of selected PET tracers in embryonated chicken eggs. Rev Esp Med Nucl Imagen Mol. 2013;32(6):371\u20137.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"3","key":"323_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nucmedbio.2014.10.010","volume":"42","author":"S Haller","year":"2015","unstructured":"Haller S, Ametamey SM, Schibli R, M\u00fcller C. Investigation of the chick embryo as a potential alternative to the mouse for evaluation of radiopharmaceuticals. Nucl Med Biol. 2015;42(3):226\u201333.","journal-title":"Nucl Med Biol"},{"issue":"1","key":"323_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1102\/1470-7330.2005.0006","volume":"5","author":"RJ Hicks","year":"2005","unstructured":"Hicks RJ. The role of PET in monitoring therapy. Cancer Imaging. 2005;5(1):51\u20137.","journal-title":"Cancer Imaging"},{"issue":"4","key":"323_CR19","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/cancers15041126","volume":"15","author":"C Hilbrig","year":"2023","unstructured":"Hilbrig C, L\u00f6ffler J, Fischer G, Scheidhauer E, Solbach C, Huber-Lang M, et al. Evaluation of the EPR effect in the CAM-model by molecular imaging with MRI and PET using 89Zr-labeled HSA. Cancers (Basel). 2023;15(4):1126.","journal-title":"Cancers (Basel)"},{"key":"323_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.omtm.2018.02.009","volume":"9","author":"J Hu","year":"2018","unstructured":"Hu J, Schokrpur S, Archang M, Hermann K, Sharrow AC, Khanna P, et al. A non-integrating lentiviral approach overcomes Cas9-induced immune rejection to establish an immunocompetent metastatic renal cancer model. Mol Ther Methods Clin Dev. 2018;9:203\u201310.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"323_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/pcmedi\/pbz018","volume":"2","author":"J Hu","year":"2019","unstructured":"Hu J, Ishihara M, Chin AI, Wu L. Establishment of xenografts of urological cancers on chicken chorioallantoic membrane (CAM) to study metastasis. Precis Clin Med. 2019;2(3):140\u201351.","journal-title":"Precis Clin Med"},{"issue":"4","key":"323_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/cpr.12268","volume":"49","author":"T Jubin","year":"2016","unstructured":"Jubin T, Kadam A, Jariwala M, Bhatt S, Sutariya S, Gani AR, et al. The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival. Cell Prolif. 2016;49(4):421\u201337.","journal-title":"Cell Prolif"},{"issue":"2","key":"323_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF00306727","volume":"147","author":"C Kind","year":"1975","unstructured":"Kind C. The development of the circulating blood volume of the chick embryo. Anat Embryol. 1975;147(2):127\u201332.","journal-title":"Anat Embryol"},{"key":"323_CR24","doi-asserted-by":"crossref","unstructured":"Laemmerer A, Lehmann C, Mayr L, Bruckner K, Gabler L, Senfter D, et al. Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens. Neuro Oncol. 2024;noae228","DOI":"10.1093\/neuonc\/noae228"},{"issue":"1","key":"323_CR25","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.210070","volume":"4","author":"HS Lee","year":"2022","unstructured":"Lee HS, Schwarz SW, Schubert EK, Chen DL, Doot RK, Makvandi M, et al. The development of 18F Fluorthanatrace: A PET radiotracer for imaging poly (ADP-ribose) polymerase-1. Radiol Imaging Cancer. 2022;4(1):e210070.","journal-title":"Radiol Imaging Cancer"},{"key":"323_CR26","doi-asserted-by":"crossref","unstructured":"Lemm S, K\u00f6hler S, Wodtke R, Jung F, K\u00fcpper JH, Pietzsch J, et al. Investigation of radiotracer metabolic stability in vitro with CYP-overexpressing hepatoma cell lines. Cells. 2022;11(15):2447.","DOI":"10.3390\/cells11152447"},{"key":"323_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12916-015-0425-1","volume":"13","author":"L Livraghi","year":"2015","unstructured":"Livraghi L, Garber JE. PARP inhibitors in the management of breast cancer: current data and future prospects. BMC Med. 2015;13:188.","journal-title":"BMC Med"},{"issue":"16","key":"323_CR28","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.3390\/cancers13164007","volume":"13","author":"J L\u00f6ffler","year":"2021","unstructured":"L\u00f6ffler J, Hamp C, Scheidhauer E, Di Carlo D, Solbach C, Abaei A, et al. Comparison of quantification of target-specific accumulation of [18F]F-siPSMA-14 in the HET-CAM model and in mice using PET\/MRI. Cancers (Basel). 2021;13(16):4007.","journal-title":"Cancers"},{"issue":"5","key":"323_CR29","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1172\/JCI97992","volume":"128","author":"M Makvandi","year":"2018","unstructured":"Makvandi M, Pantel A, Schwartz L, Schubert E, Xu K, Hsieh CJ, et al. A PET imaging agent for evaluating PARP-1 expression in ovarian cancer. J Clin Invest. 2018;128(5):2116\u201326.","journal-title":"J Clin Invest"},{"issue":"28","key":"323_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202400581","volume":"30","author":"M Ozenil","year":"2024","unstructured":"Ozenil M, Kogler L, Mair BA, Hacker M, Wadsak W, Rotstein BH, et al. Intramolecular Friedel-Crafts acylation of [11C]isocyanates enabling the radiolabeling of [carbonyl-11C]DPQ. Chemistry. 2024;30(28):e202400581.","journal-title":"Chemistry"},{"issue":"8","key":"323_CR31","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1158\/1078-0432.CCR-22-1602","volume":"29","author":"AR Pantel","year":"2023","unstructured":"Pantel AR, Gitto SB, Makvandi M, Kim H, Medvedv S, Weeks JK, et al. [18F]FluorThanatrace ([18F]FTT) PET imaging of PARP-inhibitor drug-target engagement as a biomarker of response in ovarian cancer, a pilot study. Clin Cancer Res. 2023;29(8):1515\u201327.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"323_CR32","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3390\/cancers15061704","volume":"15","author":"RA Ranjan","year":"2023","unstructured":"Ranjan RA, Muenzner JK, Kunze P, Geppert CI, Ruebner M, Huebner H, et al. The chorioallantoic membrane xenograft assay as a reliable model for investigating the biology of breast cancer. Cancers (Basel). 2023;15(6):1704.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"323_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11064-012-0887-x","volume":"38","author":"M Scalia","year":"2013","unstructured":"Scalia M, Satriano C, Greca R, Stella AMG, Rizzarelli E, Spina-Purrello V. PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells. Neurochem Res. 2013;38(1):50\u20138.","journal-title":"Neurochem Res"},{"issue":"13","key":"323_CR34","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1158\/1078-0432.CCR-19-3484","volume":"26","author":"H Sch\u00f6der","year":"2020","unstructured":"Sch\u00f6der H, Fran\u00e7a PDDS, Nakajima R, Burnazi E, Roberts S, Brand C, et al. Safety and feasibility of PARP1\/2 imaging with 18F-PARPi in patients with head and neck cancer. Clin Cancer Res. 2020;26(13):3110\u20136.","journal-title":"Clin Cancer Res"},{"issue":"5\u20136","key":"323_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1101\/gad.334516.119","volume":"34","author":"D Slade","year":"2020","unstructured":"Slade D. PARP and PARG inhibitors in cancer treatment. Genes Dev. 2020;34(5\u20136):360\u201394.","journal-title":"Genes Dev"},{"issue":"1","key":"323_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44303-023-00001-3","volume":"1","author":"LM Smith","year":"2023","unstructured":"Smith LM, Greenwood HE, Tyrrell WE, Edwards RS, de Santis V, Baark F, et al. The chicken chorioallantoic membrane as a low-cost, high-throughput model for cancer imaging. Npj Imaging. 2023;1(1):1.","journal-title":"npj Imaging"},{"issue":"3","key":"323_CR37","first-page":"834","volume":"49","author":"S Stotz","year":"2022","unstructured":"Stotz S, Kinzler J, Nies AT, Schwab M, Maurer A. Two experts and a newbie: [18F]PARPi vs [18F]FTT vs [18F]FPyPARP-a comparison of PARP imaging agents. EJNMMI. 2022;49(3):834\u201346.","journal-title":"EJNMMI"},{"issue":"36","key":"323_CR38","doi-asserted-by":"publisher","first-page":"E7441","DOI":"10.1073\/pnas.1705013114","volume":"114","author":"J Tang","year":"2017","unstructured":"Tang J, Salloum D, Carney B, Brand C, Kossatz S, Sadique A, et al. Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma. Proc Natl Acad Sci USA. 2017;114(36):E7441\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"323_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.nucmedbio.2005.03.001","volume":"32","author":"Z Tu","year":"2005","unstructured":"Tu Z, Chu W, Zhang J, Dence CS, Welch MJ, Mach RH. Synthesis and in vivo evaluation of [11C]PJ34, a potential radiotracer for imaging the role of PARP-1 in necrosis. Nucl Med Biol. 2005;32(5):437\u201343.","journal-title":"Nucl Med Biol"},{"issue":"11","key":"323_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079757","volume":"8","author":"G Wang","year":"2013","unstructured":"Wang G, Huang X, Li Y, Guo K, Ning P, Zhang Y. PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-\u03baB-mediated inflammatory response. PLoS ONE. 2013;8(11):e79757.","journal-title":"PLoS ONE"},{"issue":"3","key":"323_CR41","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3892\/mmr.2014.2977","volume":"11","author":"J Wang","year":"2015","unstructured":"Wang J, Hao L, Wang Y, Qin W, Wang X, Zhao T, et al. Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis. Mol Med Rep. 2015;11(3):1768\u201376.","journal-title":"Mol Med Rep"},{"issue":"9","key":"323_CR42","first-page":"2606","volume":"50","author":"X Wang","year":"2023","unstructured":"Wang X, Liu W, Li K, Chen K, He S, Zhang J, et al. PET imaging of PARP expression using 68Ga-labelled inhibitors. EJNMMI. 2023;50(9):2606\u201320.","journal-title":"EJNMMI"},{"issue":"10","key":"323_CR43","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.2967\/jnumed.112.117150","volume":"54","author":"G Warnock","year":"2013","unstructured":"Warnock G, Turtoi A, Blomme A, Bretin F, Bahri MA, Lemaire C, et al. In vivo PET\/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development. J Nucl Med. 2013;54(10):1782\u20138.","journal-title":"J Nucl Med"},{"issue":"20","key":"323_CR44","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1200\/JCO.2006.06.6068","volume":"24","author":"WA Weber","year":"2006","unstructured":"Weber WA. Positron emission tomography as an imaging biomarker. J Clin Oncol. 2006;24(20):3282\u201392.","journal-title":"J Clin Oncol"},{"issue":"4","key":"323_CR45","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2967\/jnumed.118.213223","volume":"60","author":"TC Wilson","year":"2019","unstructured":"Wilson TC, Xavier MA, Knight J, Verhoog S, Torres JB, Mosley M, et al. PET imaging of PARP expression using 18F-Olaparib. J Nucl Med. 2019;60(4):504\u201310.","journal-title":"J Nucl Med"},{"issue":"6","key":"323_CR46","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s11307-012-0550-6","volume":"14","author":"L W\u00fcrbach","year":"2012","unstructured":"W\u00fcrbach L, Heidrich A, Opfermann T, Gebhardt P, Saluz HP. Insights into bone metabolism of avian embryos in ovo via 3D and 4D 18F-fluoride positron emission tomography. Mol Imaging and Biol. 2012;14(6):688\u201398.","journal-title":"Mol Imaging and Biol"},{"issue":"1","key":"323_CR47","volume":"2","author":"RJ Young","year":"2020","unstructured":"Young RJ, Fran\u00e7a PDDS, Pirovano G, Piotrowski AF, Nicklin PJ, Riedl CC, et al. Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET\/MR. Neurooncol Adv. 2020;2(1):vdaa119.","journal-title":"Neurooncol Adv"},{"issue":"5","key":"323_CR48","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1021\/acs.molpharmaceut.4c00262","volume":"21","author":"W Zheng","year":"2024","unstructured":"Zheng W, Huang Y, Xie Y, Yang T, Cheng X, Chen H, et al. Design, synthesis, and evaluation of [18F]BIBD-300 as a positron emission tomography tracer for poly(ADP-ribose) polymerase-1. Mol Pharm. 2024;21(5):2606\u201321.","journal-title":"Mol Pharm"},{"issue":"5","key":"323_CR49","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.bmc.2014.01.019","volume":"22","author":"D Zhou","year":"2014","unstructured":"Zhou D, Chu W, Xu J, Jones LA, Peng X, Li S, et al. Synthesis, [18F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography. Bioorg Med Chem. 2014;22(5):1700\u20137.","journal-title":"Bioorg Med Chem"},{"key":"323_CR50","doi-asserted-by":"crossref","unstructured":"Zhou D, Xu J, Mpoy C, Chu W, Kim SH, Li H, et al. Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer. Nucl Med Biol. 2018;66:26\u201331","DOI":"10.1016\/j.nucmedbio.2018.08.003"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-024-00323-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-024-00323-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-024-00323-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T12:04:57Z","timestamp":1736510697000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmipharmchem.springeropen.com\/articles\/10.1186\/s41181-024-00323-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1186\/s41181-024-00323-6","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The here employed methodology using fertilised chicken eggs (in ovo) is not an animal experiment according to the Austrian Animal Testing Act 2012 (\u201cTiereversuchsgesetz\u201d 2012) as neither live vertebrates nor mammalian foetuses are used (Sect.\u00a01 para. 1), nor are animals born or hatched (Sect.\u00a01 para. 1 lit. b).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}